opc 12759 has been researched along with glutamine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Higaki, K; Kimura, T; Minami, T; Miyake, M; Odomi, M; Ogawara, K; Oka, Y; Toguchi, H | 1 |
Kanamitsu, K; Kikuchi, A; Maeda, T; Odomi, M; Sasabe, H; Tamai, I; Tanaka, M; Tomoyasu, T | 1 |
3 other study(ies) available for opc 12759 and glutamine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Combinatorial use of sodium laurate with taurine or L-glutamine enhances colonic absorption of rebamipide, poorly absorbable antiulcer drug, without any serious histopathological mucosal damages.
Topics: Adjuvants, Pharmaceutic; Administration, Oral; Alanine; Amino Acids; Animals; Anti-Ulcer Agents; Biological Availability; Colon; Cytoprotection; Glutamine; Intestinal Absorption; Intestinal Mucosa; Lauric Acids; Male; Quinolones; Rats; Rats, Sprague-Dawley; Taurine | 2003 |
Peptide derivation of poorly absorbable drug allows intestinal absorption via peptide transporter.
Topics: Alanine; Animals; Biological Availability; Caco-2 Cells; Chromatography, High Pressure Liquid; Dipeptides; Enzyme Inhibitors; Glutamine; HeLa Cells; Humans; In Vitro Techniques; Indicators and Reagents; Intestinal Absorption; Intestinal Mucosa; Intestines; Oocytes; Patch-Clamp Techniques; Peptide Transporter 1; Peptides; Quinolones; Rats; Regional Blood Flow; Sodium Dodecyl Sulfate; Symporters; Taurine; Xenopus | 2009 |